Karen Strike
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karen Strike has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Kam Chuen Chan
McMaster University, Hamilton, Canada
9 shared publications - Alfonso Iorio
Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada
3 shared publications - Kay Decker
Hamilton Niagara Regional Hemophilia Program, McMaster Children's Hospital, Hamilton Health Sciences , Hamilton , ON , Canada
3 shared publications - Monica R. Maly
Department of Kinesiology and Health Science, University of Waterloo, Waterloo, ON, Canada
3 shared publications - Patricia Solomon
School of Rehabilitation Science, Faculty of Health Sciences, McMaster University
3 shared publications Anastasia N.L. Newman
From the: From the: School of Rehabilitation Science, Faculty of Health Science, McMaster University, Hamilton, Ontario, Canada, L8S1C7
2 shared publications
Latest Publications
- Open Access
- 13 January 2026
- Published by Wiley in Haemophilia
- Vol. 32 (2) , 534-542
Reference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry
Background: People with haemophilia (PwH) are at increased risk of joint bleeding, often leading to haemophilic arthropathy. The Haemophilia Joint Health Score (HJHS) is widely used to evaluate joint health, but its interpretability is limited by the lack of age‐based reference values. Objective: This study aimed to develop national reference values for the HJHS in individuals with severe haemophilia using data from the Canadian Bleeding Disorder Registry (CBDR). Methods: This cross‐sectional study used CBDR data from 1 January 2018 to 31 December 2024. Participants aged ≥4 years with severe Haemophilia A or B and at least one HJHS score were included. Generalised Additive Models for Location, Scale, and Shape (GAMLSS) were used to estimate reference percentiles. Model performance was assessed using 100‐fold cross‐validation. Results: A total of 551 participants with severe haemophilia were included, comprising 255 paediatric (<18 years of age) and 296 adult patients (mean age: 24 ± 17 years; range: 4–75; 87% with Haemophilia A). Reference percentiles (fifth to 95th) were generated for ages 4–70 years, demonstrating a positive association between age and HJHS scores. Cross‐validation showed acceptable model consistency. Conclusion: This study provides the first national age‐based reference values for the HJHS in individuals with severe Haemophilia A and B. These values allow clinicians to interpret joint health scores relative to age‐specific expectations. Future research should extend age‐specific HJHS reference values to additional national registries to strengthen global interpretation and comparison of joint health outcomes.
- 13 January 2026
- Published by Wiley in Haemophilia
- Vol. 32 (2) , 534-542
Open AccessReference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry
Background: People with haemophilia (PwH) are at increased risk of joint bleeding, often leading to haemophilic arthropathy. The Haemophilia Joint Health Score (HJHS) is widely used to evaluate joint health, but its interpretability is limited by the lack of age‐based reference values. Objective: This study aimed to develop national reference values for the HJHS in individuals with severe haemophilia using data from the Canadian Bleeding Disorder Registry (CBDR). Methods: This cross‐sectional study used CBDR data from 1 January 2018 to 31 December 2024. Participants aged ≥4 years with severe Haemophilia A or B and at least one HJHS score were included. Generalised Additive Models for Location, Scale, and Shape (GAMLSS) were used to estimate reference percentiles. Model performance was assessed using 100‐fold cross‐validation. Results: A total of 551 participants with severe haemophilia were included, comprising 255 paediatric (<18 years of age) and 296 adult patients (mean age: 24 ± 17 years; range: 4–75; 87% with Haemophilia A). Reference percentiles (fifth to 95th) were generated for ages 4–70 years, demonstrating a positive association between age and HJHS scores. Cross‐validation showed acceptable model consistency. Conclusion: This study provides the first national age‐based reference values for the HJHS in individuals with severe Haemophilia A and B. These values allow clinicians to interpret joint health scores relative to age‐specific expectations. Future research should extend age‐specific HJHS reference values to additional national registries to strengthen global interpretation and comparison of joint health outcomes.
- Open Access
- 20 July 2025
- Published by Wiley in Haemophilia
- Vol. 31 (5) , 840-864
Measuring Physical Function Capacity in Persons With Haemophilia: A Systematic Review of Performance‐Based Methods
Introduction: Currently, physical health assessments in persons with haemophilia focus on bleed‐related events and after‐effects. The aim of the systematic review was to review and apply standardised criteria to evaluate reliability, responsiveness and construct validity of performance‐based instruments evaluating physical capability in persons with haemophilia. Methods: Medline, CINAHL, Embase, EMCARE, and Cochrane (inception‐March 2024) were searched using COSMIN filters for 7 performance‐based tests in haemophilia, supplemented by manual searches. Reliability, responsiveness and construct validity of the six‐minute walk test (6MWT), timed up and go test (TUG), timed up and down stairs (TUDS), 30‐second sit‐to‐stand (30‐STS), single leg stance (SLS), tandem stance (TS) and single hop for distance (SH) were evaluated. Results: The search yielded 88 abstracts; 25 studies remained after full‐text screening, covering 5 of 7 performance‐based instruments: 6MWT, TUG, TUDS, SLS, and 30‐STS. No performance‐based test was evaluated for all properties across all ages. Only TUG in adults and older adults and 6MWT in children and adolescents has been tested for all properties. No test received a high grading. Low and very low grades were given mostly for indeterminate results, small or single studies and lack of a similar construct of comparator. The 6MWT in all age groups was the only performance‐based test graded moderate, and this was for responsiveness. Conclusion: With increasing use of performance‐based methods of physical function capacity, evaluating measurement properties is a priority. Until evidence is generated, we can only advocate the 6MWT to monitor responsiveness in adult persons with haemophilia affected with marked arthropathy. Summary: Understanding Physical Health in People with Haemophilia Currently, when we check the physical health of people with haemophilia, we mostly look at problems caused by bleeding. But we wanted to see if there are better ways to measure how well people with haemophilia can move and do daily activities. What We Did We looked through a lot of medical studies (up to March 2024) to find information on 7 specific physical tests. These tests measure things like: How far someone can walk in six minutes (6‐minute walk test or 6MWT) How long it takes to stand up, walk a short distance, and sit down (Timed Up and Go test or TUG) How long it takes to go up and down stairs (timed up and down stairs or TUDS) How many times someone can stand up from a chair in 30 seconds (30‐second sit‐to‐stand or 30‐STS) How long someone can stand on one leg (single leg stance or SLS) How long someone can stand with one foot directly in front of the other (Tandem Stance or TS) How far someone can hop on one leg (single hop for distance or SH) We wanted to see how reliable (consistent), responsive (can detect changes), and valid (measures what it's supposed to) these tests were for people with haemophilia. What We Found We found 25 studies that looked at 5 of the 7 tests (6MWT, TUG, TUDS, SLS, and 30‐STS). Here's what stood out: No single test was good for everything and for all ages. Only the TUG test (for adults) and the 6MWT (for children) had been fully studied for all aspects (reliability, responsiveness, and validity). None of the tests were rated as highly effective overall. Most got low ratings because the results weren't clear, studies were small, or there wasn't enough good information to compare them to. The 6MWT was the only test that received a ‘moderate‘ rating, but only for its ability to show changes in all age groups. What This Means It's becoming more common to use these kinds of physical tests to understand how well people function. So, it's very important to know if these tests work well for people with haemophilia. For now, based on the evidence, we can only suggest using the 6‐minute walk test (6MWT) to track how much someone's physical ability changes over time, especially for adults with haemophilia who have severe joint problems. We need more research to find better tests.
- 20 July 2025
- Published by Wiley in Haemophilia
- Vol. 31 (5) , 840-864
Open AccessMeasuring Physical Function Capacity in Persons With Haemophilia: A Systematic Review of Performance‐Based Methods
Introduction: Currently, physical health assessments in persons with haemophilia focus on bleed‐related events and after‐effects. The aim of the systematic review was to review and apply standardised criteria to evaluate reliability, responsiveness and construct validity of performance‐based instruments evaluating physical capability in persons with haemophilia. Methods: Medline, CINAHL, Embase, EMCARE, and Cochrane (inception‐March 2024) were searched using COSMIN filters for 7 performance‐based tests in haemophilia, supplemented by manual searches. Reliability, responsiveness and construct validity of the six‐minute walk test (6MWT), timed up and go test (TUG), timed up and down stairs (TUDS), 30‐second sit‐to‐stand (30‐STS), single leg stance (SLS), tandem stance (TS) and single hop for distance (SH) were evaluated. Results: The search yielded 88 abstracts; 25 studies remained after full‐text screening, covering 5 of 7 performance‐based instruments: 6MWT, TUG, TUDS, SLS, and 30‐STS. No performance‐based test was evaluated for all properties across all ages. Only TUG in adults and older adults and 6MWT in children and adolescents has been tested for all properties. No test received a high grading. Low and very low grades were given mostly for indeterminate results, small or single studies and lack of a similar construct of comparator. The 6MWT in all age groups was the only performance‐based test graded moderate, and this was for responsiveness. Conclusion: With increasing use of performance‐based methods of physical function capacity, evaluating measurement properties is a priority. Until evidence is generated, we can only advocate the 6MWT to monitor responsiveness in adult persons with haemophilia affected with marked arthropathy. Summary: Understanding Physical Health in People with Haemophilia Currently, when we check the physical health of people with haemophilia, we mostly look at problems caused by bleeding. But we wanted to see if there are better ways to measure how well people with haemophilia can move and do daily activities. What We Did We looked through a lot of medical studies (up to March 2024) to find information on 7 specific physical tests. These tests measure things like: How far someone can walk in six minutes (6‐minute walk test or 6MWT) How long it takes to stand up, walk a short distance, and sit down (Timed Up and Go test or TUG) How long it takes to go up and down stairs (timed up and down stairs or TUDS) How many times someone can stand up from a chair in 30 seconds (30‐second sit‐to‐stand or 30‐STS) How long someone can stand on one leg (single leg stance or SLS) How long someone can stand with one foot directly in front of the other (Tandem Stance or TS) How far someone can hop on one leg (single hop for distance or SH) We wanted to see how reliable (consistent), responsive (can detect changes), and valid (measures what it's supposed to) these tests were for people with haemophilia. What We Found We found 25 studies that looked at 5 of the 7 tests (6MWT, TUG, TUDS, SLS, and 30‐STS). Here's what stood out: No single test was good for everything and for all ages. Only the TUG test (for adults) and the 6MWT (for children) had been fully studied for all aspects (reliability, responsiveness, and validity). None of the tests were rated as highly effective overall. Most got low ratings because the results weren't clear, studies were small, or there wasn't enough good information to compare them to. The 6MWT was the only test that received a ‘moderate‘ rating, but only for its ability to show changes in all age groups. What This Means It's becoming more common to use these kinds of physical tests to understand how well people function. So, it's very important to know if these tests work well for people with haemophilia. For now, based on the evidence, we can only suggest using the 6‐minute walk test (6MWT) to track how much someone's physical ability changes over time, especially for adults with haemophilia who have severe joint problems. We need more research to find better tests.
- Open Access
- 4 November 2024
- Published by Wiley in Haemophilia
- Vol. 30 (6) , 1265-1271
The haemophilia joint health score for the assessment of joint health in patients with haemophilia
Introduction: The haemophilia joint health score (HJHS) is a tool used to assess joint changes in patients with haemophilia. There is lack of consensus on the interpretation of HJHS scores and their clinical relevance.Aim: To evaluate available literature reporting HJHS changes over time and assess a possible cut‐off value for clinically relevant outcomes and the ideal follow‐up for a meaningful score change.Methods: We conducted a literature search of studies published between 2011 and 2023 where the HJHS version 2.1 had been adopted to detect changes in joint health in patients with haemophilia. We focused on studies that assessed clinical relevance of HJHS changes, evaluated the use of cut‐off values and reported a follow‐up over time.Results: Our search identified 213 publications of which 53 (25%) were deemed relevant for this review. Of these, 33 (62%) publications reported the total HJHS score and 20 (38%) reported a single joint HJHS score, while the way of reporting HJHS scores/change was highly variable. Ten publications (19%) assessed clinical relevance, but their methods of calculation differed (defining a cut‐off score, measuring standardised response mean or minimal detectable change). The follow‐up duration varied from 2 weeks to 8 years in these 10 studies.Conclusions: High variability in assessing HJHS change over time is the primary consequence of its low sensitivity, and the lack of consensus on interpretation and clinical relevance of the score. Therefore, more sensitive tools should be used alongside HJHS to better define the joint health status of patients with haemophilia.
- 4 November 2024
- Published by Wiley in Haemophilia
- Vol. 30 (6) , 1265-1271
Open AccessThe haemophilia joint health score for the assessment of joint health in patients with haemophilia
Introduction: The haemophilia joint health score (HJHS) is a tool used to assess joint changes in patients with haemophilia. There is lack of consensus on the interpretation of HJHS scores and their clinical relevance.Aim: To evaluate available literature reporting HJHS changes over time and assess a possible cut‐off value for clinically relevant outcomes and the ideal follow‐up for a meaningful score change.Methods: We conducted a literature search of studies published between 2011 and 2023 where the HJHS version 2.1 had been adopted to detect changes in joint health in patients with haemophilia. We focused on studies that assessed clinical relevance of HJHS changes, evaluated the use of cut‐off values and reported a follow‐up over time.Results: Our search identified 213 publications of which 53 (25%) were deemed relevant for this review. Of these, 33 (62%) publications reported the total HJHS score and 20 (38%) reported a single joint HJHS score, while the way of reporting HJHS scores/change was highly variable. Ten publications (19%) assessed clinical relevance, but their methods of calculation differed (defining a cut‐off score, measuring standardised response mean or minimal detectable change). The follow‐up duration varied from 2 weeks to 8 years in these 10 studies.Conclusions: High variability in assessing HJHS change over time is the primary consequence of its low sensitivity, and the lack of consensus on interpretation and clinical relevance of the score. Therefore, more sensitive tools should be used alongside HJHS to better define the joint health status of patients with haemophilia.
- 18 April 2024
- Published by Wiley in Haemophilia
- Vol. 30 (3) , 862-864
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
- 18 April 2024
- Published by Wiley in Haemophilia
- Vol. 30 (3) , 862-864
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
- 27 November 2023
- Published by University of Toronto Press Inc. (UTPress) in Physiotherapy Canada
- Vol. 75 (4) , 322-336
Scoping Review of Curricula and Pedagogical Approaches for Physiotherapist Performed Point of Care Ultrasonography
Purpose: This study collates and maps physiotherapy pre- and post-licensure curricula and pedagogical approaches for point of care ultrasonography (POCUS). Method: We used a standardized scoping review methodology and reporting framework. A total of 18,217 titles and abstracts, and 1,372 full text citations were screened, with 209 studies classified as physiotherapist performed POCUS. Results: Of the 209 studies, 15 evaluated pre- and post-licensure curricula and pedagogical approaches. Seventy-two to 98% of pre-licensure programs reported including theoretical knowledge of POCUS and 44–45% reported practical teaching or competency assessment. In post-licensure studies of POCUS, 0–61% of physiotherapists reported training for POCUS. All studies of post-licensure pedagogical approaches included an assessment of theoretical knowledge of POCUS, but only one study included a practical assessment of competency. There was considerable variability in POCUS methods and duration of pedagogical approaches. Except for one study, all pedagogical approaches reported improvement in theoretical knowledge. Conclusion: Progress in physiotherapy-specific, standardized, competency-based curricula and pedagogical approaches in POCUS has been limited, with minimal research available, and considerable variability both pre- and post-licensure. These findings could be used to advocate for the inclusion of POCUS in pre- and post-licensure physiotherapy curriculum, and suggest a need for clear guidelines from regulatory colleges and licensing bodies, and a common terminology for physiotherapist performed POCUS. Future directions for research include a systematic review of the psychometric properties of physiotherapist performed POCUS within and across anatomical areas, an assessment of value of different forms of training, and an evaluation of the impact of physiotherapist performed POCUS on patient outcomes.
- 27 November 2023
- Published by University of Toronto Press Inc. (UTPress) in Physiotherapy Canada
- Vol. 75 (4) , 322-336
Scoping Review of Curricula and Pedagogical Approaches for Physiotherapist Performed Point of Care Ultrasonography
Purpose: This study collates and maps physiotherapy pre- and post-licensure curricula and pedagogical approaches for point of care ultrasonography (POCUS). Method: We used a standardized scoping review methodology and reporting framework. A total of 18,217 titles and abstracts, and 1,372 full text citations were screened, with 209 studies classified as physiotherapist performed POCUS. Results: Of the 209 studies, 15 evaluated pre- and post-licensure curricula and pedagogical approaches. Seventy-two to 98% of pre-licensure programs reported including theoretical knowledge of POCUS and 44–45% reported practical teaching or competency assessment. In post-licensure studies of POCUS, 0–61% of physiotherapists reported training for POCUS. All studies of post-licensure pedagogical approaches included an assessment of theoretical knowledge of POCUS, but only one study included a practical assessment of competency. There was considerable variability in POCUS methods and duration of pedagogical approaches. Except for one study, all pedagogical approaches reported improvement in theoretical knowledge. Conclusion: Progress in physiotherapy-specific, standardized, competency-based curricula and pedagogical approaches in POCUS has been limited, with minimal research available, and considerable variability both pre- and post-licensure. These findings could be used to advocate for the inclusion of POCUS in pre- and post-licensure physiotherapy curriculum, and suggest a need for clear guidelines from regulatory colleges and licensing bodies, and a common terminology for physiotherapist performed POCUS. Future directions for research include a systematic review of the psychometric properties of physiotherapist performed POCUS within and across anatomical areas, an assessment of value of different forms of training, and an evaluation of the impact of physiotherapist performed POCUS on patient outcomes.
- Open Access
- 15 October 2023
- Published by Wiley in Haemophilia
- Vol. 29 (6) , 1611-1620
Identifying performance‐based outcome measures of physical function in people with haemophilia (IPOP)
Introduction: Recent recommendations of core outcome sets for haemophilia highlight the need for including measures of performance‐based physical health and physical function sustainability. To date, there is no consensus on what outcomes might be of value to clinicians and patients.Aim: To identify instruments of performance‐based physical function to monitor musculoskeletal health in people with haemophilia that are practical in the clinical setting.Methods: Utilising components from the Activities and Participation Category of the WHO International Classification of Functioning (WHO‐ICF), a consensus‐based, decision analysis approach was used to: identify activities people with haemophilia have most difficulty performing; identify quantitative performance‐based measures of identified activities via a scoping review; and obtain views on acceptability of the tests utilising a DELPHI approach.Results: Eleven activities were identified: maintaining a standing position, walking long distances, walking up and down stairs, walking on different surfaces, running, hopping, jumping, squatting, kneeling, undertaking a complex lower limb task, undertaking a complex upper limb task. Following a 2‐round DELPHI survey of international physiotherapists, the 6‐min walk test, timed up and down stairs, 30‐s sit to stand, single leg stance, tandem stance, single hop for distance (children only) and timed up and go (adults only) reached consensus.Conclusion: This study is the first step in defining a core set of performance‐based instruments to monitor physical health and sustainability of physical function outcomes in people with haemophilia. Establishing the psychometric properties of the instruments and whether they are meaningful to people with haemophilia is essential.
- 15 October 2023
- Published by Wiley in Haemophilia
- Vol. 29 (6) , 1611-1620
Open AccessIdentifying performance‐based outcome measures of physical function in people with haemophilia (IPOP)
Introduction: Recent recommendations of core outcome sets for haemophilia highlight the need for including measures of performance‐based physical health and physical function sustainability. To date, there is no consensus on what outcomes might be of value to clinicians and patients.Aim: To identify instruments of performance‐based physical function to monitor musculoskeletal health in people with haemophilia that are practical in the clinical setting.Methods: Utilising components from the Activities and Participation Category of the WHO International Classification of Functioning (WHO‐ICF), a consensus‐based, decision analysis approach was used to: identify activities people with haemophilia have most difficulty performing; identify quantitative performance‐based measures of identified activities via a scoping review; and obtain views on acceptability of the tests utilising a DELPHI approach.Results: Eleven activities were identified: maintaining a standing position, walking long distances, walking up and down stairs, walking on different surfaces, running, hopping, jumping, squatting, kneeling, undertaking a complex lower limb task, undertaking a complex upper limb task. Following a 2‐round DELPHI survey of international physiotherapists, the 6‐min walk test, timed up and down stairs, 30‐s sit to stand, single leg stance, tandem stance, single hop for distance (children only) and timed up and go (adults only) reached consensus.Conclusion: This study is the first step in defining a core set of performance‐based instruments to monitor physical health and sustainability of physical function outcomes in people with haemophilia. Establishing the psychometric properties of the instruments and whether they are meaningful to people with haemophilia is essential.
- 19 November 2022
- Published by Elsevier in Physiotherapy
- Vol. 119, 34-43
Physiotherapist performed Point of Care Ultrasonography (POCUS): a scoping review of 209 studies
- 19 November 2022
- Published by Elsevier in Physiotherapy
- Vol. 119, 34-43
Physiotherapist performed Point of Care Ultrasonography (POCUS): a scoping review of 209 studies
- Open Access
- 1 January 2022
- Published by Haemnet Ltd in The Journal of Haemophilia Practice
- Vol. 9 (1) , 64-75
Point of care ultrasonography in patients with haemophilia and acute haemarthrosis: a physiotherapist and sonographer inter-professional agreement pilot study
Background: Haemophilia treatment centres (HTCs) around the world are increasingly adopting point-of-care ultrasonography (POCUS) for the assessment of acute haemarthrosis and to monitor joint health. POCUS is in large part administered by physiotherapists in most comprehensive care teams. Appropriate implementation of haemophilia-specific POCUS requires an educational foundation and training to ensure competency and optimal outcomes. Inter-professional agreement and evaluation of image quality are important measures of competency and acceptable use of POCUS. Aims: To determine the level of agreement between physiotherapist and sonographer-performed POCUS scans and to compare the quality of the ultrasound images obtained by physiotherapists to those obtained by the sonographer. Methods: This single blind, prospective, pilot study recruited patients with haemophilia A and B who presented to clinic with a suspected acute haemarthrosis of the elbow, knee, or ankle and consented to participate. POCUS scans were performed by one trained physiotherapist and one sonographer in the haemophilia ambulatory clinic at patient presentation, one-week follow-up, and two-week follow-up. The physiotherapist participated in formal training consisting of 12 hours of online didactic modules and a two-day, 12-hour practical module with instructor-led hands-on training. For the primary objective, the outcome of interest was the binary decision on the presence or absence of blood within the joint. For the secondary objective, image quality was evaluated by the radiologist post hoc and rated as optimal, acceptable, or sub-optimal. Results: Thirteen participants with haemophilia consented to the study. The results indicated an excellent level of agreement (k=0.80) with an observed agreement of 91.7%, a specific positive agreement of 94.1%, and a specific negative agreement of 85.7% for the detection of blood within the joint space. The quality of the ultrasound images obtained by the physiotherapist were rated by the radiologist as optimal (84.6%) and acceptable (15.4%). None of the images were rated as sub-optimal. Conclusion: Optimal image quality and a high level of agreement between the physiotherapist and sonographer-performed POCUS for the assessment of acute hemarthrosis in people with haemophilia A and B was observed. These results suggest that, with a short formal training programme, physiotherapists can be proficient in the performance, acquisition, and interpretation of POCUS scans in patients with haemophilia.
- 1 January 2022
- Published by Haemnet Ltd in The Journal of Haemophilia Practice
- Vol. 9 (1) , 64-75
Open AccessPoint of care ultrasonography in patients with haemophilia and acute haemarthrosis: a physiotherapist and sonographer inter-professional agreement pilot study
Background: Haemophilia treatment centres (HTCs) around the world are increasingly adopting point-of-care ultrasonography (POCUS) for the assessment of acute haemarthrosis and to monitor joint health. POCUS is in large part administered by physiotherapists in most comprehensive care teams. Appropriate implementation of haemophilia-specific POCUS requires an educational foundation and training to ensure competency and optimal outcomes. Inter-professional agreement and evaluation of image quality are important measures of competency and acceptable use of POCUS. Aims: To determine the level of agreement between physiotherapist and sonographer-performed POCUS scans and to compare the quality of the ultrasound images obtained by physiotherapists to those obtained by the sonographer. Methods: This single blind, prospective, pilot study recruited patients with haemophilia A and B who presented to clinic with a suspected acute haemarthrosis of the elbow, knee, or ankle and consented to participate. POCUS scans were performed by one trained physiotherapist and one sonographer in the haemophilia ambulatory clinic at patient presentation, one-week follow-up, and two-week follow-up. The physiotherapist participated in formal training consisting of 12 hours of online didactic modules and a two-day, 12-hour practical module with instructor-led hands-on training. For the primary objective, the outcome of interest was the binary decision on the presence or absence of blood within the joint. For the secondary objective, image quality was evaluated by the radiologist post hoc and rated as optimal, acceptable, or sub-optimal. Results: Thirteen participants with haemophilia consented to the study. The results indicated an excellent level of agreement (k=0.80) with an observed agreement of 91.7%, a specific positive agreement of 94.1%, and a specific negative agreement of 85.7% for the detection of blood within the joint space. The quality of the ultrasound images obtained by the physiotherapist were rated by the radiologist as optimal (84.6%) and acceptable (15.4%). None of the images were rated as sub-optimal. Conclusion: Optimal image quality and a high level of agreement between the physiotherapist and sonographer-performed POCUS for the assessment of acute hemarthrosis in people with haemophilia A and B was observed. These results suggest that, with a short formal training programme, physiotherapists can be proficient in the performance, acquisition, and interpretation of POCUS scans in patients with haemophilia.
- Open Access
- 1 January 2022
- Published by Haemnet Ltd in The Journal of Haemophilia Practice
- Vol. 9 (1) , 41-49
Development of decision-making considerations to support equitable patient selection in paediatric haemophilia trials
Background: Clinical trials for investigational haemophilia treatments such as gene therapy offer a potentially life-changing opportunity to those who are selected for enrolment. However, the number of enrolment slots available for these trials is often greatly exceeded by the number of eligible patients. Many of the strategies that are commonly used to select candidates for participation can be highly unsystematic, inequitable, and subjective. A more rigorous set of criteria is therefore needed to evaluate each candidate's suitability for trial participation in order to eliminate bias in selection and fulfill the ethical principle of justice. Aims: To review current knowledge and issues in patient selection for paediatric haemophilia clinical trials with competitive availability, and to develop a more objective standard for decision-making that takes into account the needs of all involved parties. Methods: A literature search on the ethics of trial participant selection and the practice of fairly distributing limited medical resources was conducted to identify previous literature and best practices in the area. A list of essential decision-making considerations was then designed to guide the selection of paediatric participants for haemophilia therapy trials through iterative group discussions between a diverse team of health professionals at McMaster Children's Hospital, Hamilton, ON, Canada. Results: Current practices in resolving this ethical issue are highly heterogenous, although there are some common themes and recommendations. The three main criteria supported by the team and the literature search for inclusion in the considerations were: medical need, need for support, and potential safety considerations for the patient. Three measures for evaluating each criterion were developed and added for consideration during the decision-making process. The role of patient selection in meeting the scientific aims of the trial was also considered. Conclusion: Attempting to create an equitable, systematic decision-making procedure for clinical trial participant selection involves a wide variety of competing values and ethical considerations, and discrepancies between recommendations are commonplace. The criteria presented here are intended to be used as a guideline to assist the equitable selection of paediatric patients for participation in haemophilia clinical trials with highly limited enrolment, although it may have some applicability to other areas of clinical research or therapeutic areas concerned with the allocation of scarce medical resources. Next steps should involve speaking with patients, community members and other stakeholders in order to include their perspectives. Assessment of medical need, potential support needs, and safety considerations form the basis of criteria for discussions around how to make enrolment in paediatric haemophilia clinical trials more equitable © Shutterstock
- 1 January 2022
- Published by Haemnet Ltd in The Journal of Haemophilia Practice
- Vol. 9 (1) , 41-49
Open AccessDevelopment of decision-making considerations to support equitable patient selection in paediatric haemophilia trials
Background: Clinical trials for investigational haemophilia treatments such as gene therapy offer a potentially life-changing opportunity to those who are selected for enrolment. However, the number of enrolment slots available for these trials is often greatly exceeded by the number of eligible patients. Many of the strategies that are commonly used to select candidates for participation can be highly unsystematic, inequitable, and subjective. A more rigorous set of criteria is therefore needed to evaluate each candidate's suitability for trial participation in order to eliminate bias in selection and fulfill the ethical principle of justice. Aims: To review current knowledge and issues in patient selection for paediatric haemophilia clinical trials with competitive availability, and to develop a more objective standard for decision-making that takes into account the needs of all involved parties. Methods: A literature search on the ethics of trial participant selection and the practice of fairly distributing limited medical resources was conducted to identify previous literature and best practices in the area. A list of essential decision-making considerations was then designed to guide the selection of paediatric participants for haemophilia therapy trials through iterative group discussions between a diverse team of health professionals at McMaster Children's Hospital, Hamilton, ON, Canada. Results: Current practices in resolving this ethical issue are highly heterogenous, although there are some common themes and recommendations. The three main criteria supported by the team and the literature search for inclusion in the considerations were: medical need, need for support, and potential safety considerations for the patient. Three measures for evaluating each criterion were developed and added for consideration during the decision-making process. The role of patient selection in meeting the scientific aims of the trial was also considered. Conclusion: Attempting to create an equitable, systematic decision-making procedure for clinical trial participant selection involves a wide variety of competing values and ethical considerations, and discrepancies between recommendations are commonplace. The criteria presented here are intended to be used as a guideline to assist the equitable selection of paediatric patients for participation in haemophilia clinical trials with highly limited enrolment, although it may have some applicability to other areas of clinical research or therapeutic areas concerned with the allocation of scarce medical resources. Next steps should involve speaking with patients, community members and other stakeholders in order to include their perspectives. Assessment of medical need, potential support needs, and safety considerations form the basis of criteria for discussions around how to make enrolment in paediatric haemophilia clinical trials more equitable © Shutterstock
- 29 April 2021
- Published by Wiley in Haemophilia
- Vol. 27 (4) , 674-682
Developing clinical practice guidelines for physiotherapists working with people with inherited bleeding disorders
Introduction: Several bleeding disorders are characterized by haemorrhage into joints and muscles. These conditions are best managed by interdisciplinary teams that include physiotherapists. In 1997, physiotherapists from haemophilia treatment centres in Canada formed the Canadian Physiotherapists in Hemophilia Care (CPHC). The guiding principles of the CPHC reflect a commitment to evidence‐based practice, education and collaboration.Aim: To describe the process used by CPHC to develop evidence‐based clinical practice guidelines to inform best practice, guide decision‐making and help educate physiotherapists, students, and other team members about the physiotherapy management of people with bleeding disorders.Methods: We followed the procedures outlined in the American Physical Therapy Association's Clinical Practice Guideline Process Manual (2018). Namely, we selected a working group, determined the scope of the guidelines, performed a literature search, selected and appraised the evidence, drafted the guidelines as practice statements, assigned a strength of recommendation to each practice statement and disseminated the guidelines.Results: Thirty‐nine practice statements were developed in nine practice areas. Strength of evidence was strong for two statements, moderate for one and weak for three. The remainder were graded as theoretical or best practice.Conclusion: To our knowledge, these are the first evidence‐based clinical practice guidelines that cover all aspects of physiotherapy management of people with bleeding disorders. Some areas, such as exercise and manual therapy, have been well investigated. However, the overall low levels of evidence and low strengths of recommendations highlight the need for more rigorous research with this population.
- 29 April 2021
- Published by Wiley in Haemophilia
- Vol. 27 (4) , 674-682
Developing clinical practice guidelines for physiotherapists working with people with inherited bleeding disorders
Introduction: Several bleeding disorders are characterized by haemorrhage into joints and muscles. These conditions are best managed by interdisciplinary teams that include physiotherapists. In 1997, physiotherapists from haemophilia treatment centres in Canada formed the Canadian Physiotherapists in Hemophilia Care (CPHC). The guiding principles of the CPHC reflect a commitment to evidence‐based practice, education and collaboration.Aim: To describe the process used by CPHC to develop evidence‐based clinical practice guidelines to inform best practice, guide decision‐making and help educate physiotherapists, students, and other team members about the physiotherapy management of people with bleeding disorders.Methods: We followed the procedures outlined in the American Physical Therapy Association's Clinical Practice Guideline Process Manual (2018). Namely, we selected a working group, determined the scope of the guidelines, performed a literature search, selected and appraised the evidence, drafted the guidelines as practice statements, assigned a strength of recommendation to each practice statement and disseminated the guidelines.Results: Thirty‐nine practice statements were developed in nine practice areas. Strength of evidence was strong for two statements, moderate for one and weak for three. The remainder were graded as theoretical or best practice.Conclusion: To our knowledge, these are the first evidence‐based clinical practice guidelines that cover all aspects of physiotherapy management of people with bleeding disorders. Some areas, such as exercise and manual therapy, have been well investigated. However, the overall low levels of evidence and low strengths of recommendations highlight the need for more rigorous research with this population.